FDA Adverse Event Injury Summary report: N

UNKNOWN IMPLANTABLE NEUROSTIMULATOR

MDR report key: 4947176 · Received July 28, 2015

Report

Report Number
3007566237-2015-02111
Event Type
Injury
Date Received
July 28, 2015
Date of Event
April 29, 2015
Report Date
July 1, 2015
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

PLEASE NOTE THAT THIS DATE IS BASED OFF OF THE DATE THAT THE ARTICLE WAS ACCEPTED FOR PUBLICATION AS THE EVENT DATES WERE NOT PROVIDED IN THE PUBLISHED LITERATURE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. CORRESPONDENCE HAS BEEN SENT TO THE AUTHOR OF THE ARTICLE INQUIRING ABOUT ADDITIONAL INFORMATION REGARDING THE REPORTED EVENTS. THE DEVICE WAS USED FOR AN OFF LABEL INDICATION AS IT WAS IMPLANTED TO TREAT EPILEPSY. CONCOMITANT MEDICAL PRODUCT: PRODUCT ID: NEU_UNKNOWN_LEAD, LOT# UNKNOWN, PRODUCT TYPE: LEAD. (B)(4).

Description of Event or Problem · 1

VOGES, B. R., SCHMITT, F. C., HAMEL, W., HOUSE, P. M., KLUGE, C., MOLL, C. K. E., STODIECK, S. R. DEEP BRAIN STIMULATION OF ANTERIOR NUCLEUS THALAMI DISRUPTS SLEEP IN EPILEPSY PATIENTS. EPILEPSIA. 2015; **(*): 1¿5. DOI: 10.1111/EPI.13045 SUMMARY: IN VIEW OF THE REGULATORY FUNCTION OF THE THALAMUS IN THE SLEEP-WAKE CYCLE, THE IMPACT OF DEEP BRAIN STIMULATION (DBS) OF THE ANTERIOR NUCLEUS THALAMI (ANT) ON SLEEP WAS ASSESSED IN A SMALL CONSECUTIVE COHORT OF EPILEPSY PATIENTS WITH STANDARDIZED POLYSOM NOGRAPHY (PSG). IN NINE PATIENTS TREATED WITH ANT-DBS (VOLTAGE 5 V, FREQUENCY 145 HZ, CYCLIC MODE), THE NUMBER OF AROUSALS DURING STIMULATION AND NONSTIMULATION PERIODS, NEUROPSYCHIATRIC SYMPTOMS (NPS), AND SEIZURE FREQUENCY WERE DETERMINED. ELECTROCLINICAL AROUSALS WERE TRIGGERED IN 14.0 TO 67.0% (MEAN 42.4 _ SD 16.8%) OF ALL DEEP BRAIN STIMULI. SIX PATIENTS REPORTED NPS. NOCTURNAL DBS VOLTAGES WERE REDUCED IN EIGHT PATIENTS (ONE PATIENT WITHOUT NPS REFUSED) AND PSGS WERE REPEATED. ELECTROCLINICAL AROUSALS OCCURRED BETWEEN 1.4 AND 6.7 (MEAN 3.3 _ 1.7) TIMES MORE FREQUENTLY DURING STIMULATION PERIODS COMPARED TO NONSTIMULATION PERIODS; THE NUMBER OF AROUSALS POSITIVELY CORRELATED WITH THE LEVEL OF DBS VOLTAGE (RANGE 1 V TO 5 V) (SPEARMAN0S RANK COEFFICIENT 0.53121; P <(><<)> 0.05). NO PATIENT EXPERIENCED SEIZURE DETERIORATION AND FOUR PATIENTS REPORTED REMISSION OF NPS. THIS CASE-COHORT STUDY PROVIDES EVIDENCE THAT ANT-DBS INTERRUPTS SLEEP IN A VOLTAGE-DEPENDENT MANNER, THUS PUTATIVELY RESULTING IN AN INCREASE OF NPS. REDUCTION OF NOCTURNAL DBS VOLTAGE SEEMS TO LEAD TO IMPROVEMENT OF NPS WITHOUT HAMPERING EFFICACY OF ANT-DBS. REPORTED EVENT: PATIENT 4: ONE (B)(6)-YEAR-OLD FEMALE PATIENT WITH ANTERIOR NUCLEI OF THALAMUS (ANT) DEEP BRAIN STIMULATION (DBS) FOR TREATMENT OF EPILEPSY EXPERIENCED GREATER THAN 50% REDUCTION IN SEIZURES COMPARED TO PRIOR TO DBS SURGERY. ACCORDING TO POLYSOMNOGRAPHY, THE PATIENT EXPERIENCED 4.0 DBS-RELATED AROUSALS PER HOUR AND 4 APNEAS PER HOUR WITH A NOCTURNAL VOLTAGE OF 5.0. THE PATIENT THEN HAD THE NOCTURNAL DBS VOLTAGE REDUCED TO 2.5V; IT WAS NOTED THAT THIS DECREASE IN NOCTURNAL VOLTAGE DID NOT REDUCE SEIZURE FREQUENCY BY GREATER THAN 50% COMPARED TO BEFORE THE REDUCTION. HOWEVER, THE PATIENT DID NOT EXPERIENCE SEIZURE DETERIORATION AS A RESULT. THE NUMBER OF DBS-RELATED AROUSALS WAS REDUCED TO 3.0 AROUSALS PER HOUR OF SLEEP. THE PATIENT HAD NO COMPLAINTS OF NEUROPSYCHIATRIC SIDE EFFECTS. THE SOURCE LITERATURE INCLUDED THE FOLLOWING DEVICE SPECIFICS: IMPLANTABLE NEUROSTIMULATOR ACTIVA (MODEL NUMBER NOT PROVIDED) FURTHER INFORMATION HAS BEEN REQUESTED; A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF ADDITIONAL INFORMATION IS RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
488085 UNKNOWN IMPLANTABLE NEUROSTIMULATOR STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 00039 YR Other